Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

Search Results

68 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Results By Year timeline is not available.
Page 1
Pathophysiologic correlates of thromboembolism in nonvalvular atrial fibrillation: I. Reduced flow velocity in the left atrial appendage (The Stroke Prevention in Atrial Fibrillation [SPAF-III] study).
Goldman ME, Pearce LA, Hart RG, Zabalgoitia M, Asinger RW, Safford R, Halperin JL. Goldman ME, et al. Among authors: zabalgoitia m. J Am Soc Echocardiogr. 1999 Dec;12(12):1080-7. doi: 10.1016/s0894-7317(99)70105-7. J Am Soc Echocardiogr. 1999. PMID: 10588784 Clinical Trial.
Warfarin safety and efficacy in patients with thoracic aortic plaque and atrial fibrillation. SPAF TEE Investigators. Stroke Prevention and Atrial Fibrillation. Transesophageal echocardiography.
Blackshear JL, Zabalgoitia M, Pennock G, Fenster P, Strauss R, Halperin J, Asinger R, Pearce LA. Blackshear JL, et al. Among authors: zabalgoitia m. Am J Cardiol. 1999 Feb 1;83(3):453-5, A9. doi: 10.1016/s0002-9149(98)00886-8. Am J Cardiol. 1999. PMID: 10072242 Clinical Trial.
Pathophysiologic correlates of thromboembolism in nonvalvular atrial fibrillation: II. Dense spontaneous echocardiographic contrast (The Stroke Prevention in Atrial Fibrillation [SPAF-III] study).
Asinger RW, Koehler J, Pearce LA, Zabalgoitia M, Blackshear JL, Fenster PE, Strauss R, Hess D, Pennock GD, Rothbart RM, Halperin JL. Asinger RW, et al. Among authors: zabalgoitia m. J Am Soc Echocardiogr. 1999 Dec;12(12):1088-96. doi: 10.1016/s0894-7317(99)70106-9. J Am Soc Echocardiogr. 1999. PMID: 10588785 Clinical Trial.
Mitral regurgitation associated with reduced thromboembolic events in high-risk patients with nonrheumatic atrial fibrillation. Stroke Prevention in Atrial Fibrillation Investigators.
Blackshear JL, Pearce LA, Asinger RW, Dittrich HC, Goldman ME, Zabalgoitia M, Rothbart RM, Halperin JL. Blackshear JL, et al. Among authors: zabalgoitia m. Am J Cardiol. 1993 Oct 1;72(11):840-3. doi: 10.1016/0002-9149(93)91079-w. Am J Cardiol. 1993. PMID: 8213525 No abstract available.
Variation of flow propagation velocity with age.
Mego DM, DeGeare VS, Nottestad SY, Lamanna VP, Oneschuk LC, Rubal BJ, Zabalgoitia M. Mego DM, et al. Among authors: zabalgoitia m. J Am Soc Echocardiogr. 1998 Jan;11(1):20-5. doi: 10.1016/s0894-7317(98)70116-6. J Am Soc Echocardiogr. 1998. PMID: 9487466
Analysis of cause-specific mortality in the Atrial Fibrillation Follow-up Investigation of Rhythm Management (AFFIRM) study.
Steinberg JS, Sadaniantz A, Kron J, Krahn A, Denny DM, Daubert J, Campbell WB, Havranek E, Murray K, Olshansky B, O'Neill G, Sami M, Schmidt S, Storm R, Zabalgoitia M, Miller J, Chandler M, Nasco EM, Greene HL. Steinberg JS, et al. Among authors: zabalgoitia m. Circulation. 2004 Apr 27;109(16):1973-80. doi: 10.1161/01.CIR.0000118472.77237.FA. Epub 2004 Mar 29. Circulation. 2004. PMID: 15051639 Clinical Trial.
68 results